Home / all / China Herb. Brand Minzhou. Huangdan Yinchen Keli or Huang Dan Yin Chen Ke Li or Huangdan Yinchen Granules for acute and chronic jaundice infectious hepatitis.
  • China Herb. Brand Minzhou. Huangdan Yinchen Keli or Huang Dan Yin Chen Ke Li or Huangdan Yinchen Granules for acute and chronic jaundice infectious hepatitis.
  • China Herb. Brand Minzhou. Huangdan Yinchen Keli or Huang Dan Yin Chen Ke Li or Huangdan Yinchen Granules for acute and chronic jaundice infectious hepatitis.
  • China Herb. Brand Minzhou. Huangdan Yinchen Keli or Huang Dan Yin Chen Ke Li or Huangdan Yinchen Granules for acute and chronic jaundice infectious hepatitis.
  • China Herb. Brand Minzhou. Huangdan Yinchen Keli or Huang Dan Yin Chen Ke Li or Huangdan Yinchen Granules for acute and chronic jaundice infectious hepatitis.

China Herb. Brand Minzhou. Huangdan Yinchen Keli or Huang Dan Yin Chen Ke Li or Huangdan Yinchen Granules for acute and chronic jaundice infectious hepatitis.

Quantity
ADD TO CART
BUY IT NOW
  • Detail

    黄疸茵陈颗粒

    Generic name: Jaundice Yinchen granules
    Chinese Pinyin: Huangdan Yinchen Keli
    Ingredients: Yinchen, scutellaria, rhubarb (prepared), licorice.
    Properties: This product is yellow particles; slightly fragrant and sweet.
    Functions and indications: clearing away heat and dampness, reducing jaundice. For the treatment of acute and chronic jaundice infectious hepatitis.
    Specification: 20g per bag.
    Usage and dosage: Take boiled water. 10-20g once, twice a day.
    Adverse reactions: Unclear.
    Taboo: Not clear yet.
    Note: Not clear yet.
    Storage: sealed.
    Packaging: medicinal composite film packaging, 20g×6 bags/box
    Validity period: 36 months
    Executive standard: The fourth volume of the Ministry of Standard Chinese Medicine Prescriptions.
    Standard Number: WS3-B-0828-91
    Approval number: National Medicine Standard Z62021262
    Company Name: Gansu Minhai Pharmaceutical Co., Ltd.
    Company Address: Minxian Industrial Park, Gansu

  • Customer Reviews
    No comments